Untitled

The Next Gold Rush Lithium demand’s fueling a modern-day gold rush. Essential for EVs, robots, and AI, Elon Musk said it best: “Do you like minting money? Well, the lithium business is for you.” Enter EnergyX. Their tech can recover up to 3X more lithium than traditional methods. They’ve secured a strategic investment from General Motors and POSCO, raised $150M+ in total capital, and earned a $5M Department of Energy grant. Join 40k+ people as an EnergyX investor while you still can. DISCLOSURE: EnergyX’s Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at  invest.energyx.com Free Stock Selector Checklist – Get Your Report Now Invest smarter, not harder. Use VectorVest’s Safe Stock Selector Checklist to quickly identify safe, high-performing stocks with expert precision. [ad] Get Your Free Safe Stock Selector Checklist Now. AI Created by Fmr. Nuclear Missile Coder Issues Urgent Projection for Nvidia Holders A former lieutenant colonel who worked on top secret tech for the military has now released an AI that can foresee U.S. stock prices up to 21 days in advance. What it says about Nvidia could soon affect the entire U.S. market. [ad] Click here to see this AI’s latest projection for free. Supreme Court holds off on Trump tariff ruling for now — what’s at stake for economy The court has the option to grant limited powers under the IEEPA and require only limited repayment of tariffs, along with multiple other options.Privacy Policy | Advertiser DisclosureDISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don’t trade with money you can’t afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.

Stockguru LLC (dba InvestingDistrict), 2563 cherry hill ln, Hermitage, PA 16148, United StatesYou may unsubscribe or change your contact details at any time.

Where Nvidia’s Chief Says the Next AI Fortune Lands

Nvidia’s Networking Chief just revealed where he is convinced the next AI fortune could be made. 

And here’s the best part… You don’t need to be a PhD, a Silicon Valley insider, or have millions of dollars in seed capital.

Gilad Shainer, Senior Vice President of Networking at NVIDIA, says: “A growing portion of the billions spent on AI [will land here].”

Jensen Huang, the CEO of Nvidia, agrees, calling it: “foundational to scaling AI.” 

Yet, these tech titans aren’t talking about AI chips, chatbots, or anything like that. It’s a hidden AI play few are noticing, one that’s quietly becoming one of the fastest-growing cash streams in America today.

We just recorded a video on exactly where Nvidia’s Networking Chief says billions could flow next…

Warning: if you’re only focusing on chips and chatbot stocks, you will miss this entirely.

P.S. Nvidia just announced it will spend $500 billion over the next 

4 years…But a massive chunk of that cash is headed somewhere surprising.

It’s not AI chips, chatbots, or anything similar. Yet Nvidia’s own Networking Chief says fortunes could be made here. Click here to watch the full story now.

---

Further Reading from MarketBeat Media

CrowdStrike Is Still Best-in-Breed—But 2026 May Be a Tough Trade

Author: Chris Markoch. Publication Date: 1/1/2026. 

Key Points

• CrowdStrike’s growth and cash flow remain strong, but the stock’s valuation leaves little room for disappointment.
• A post-earnings pullback looks more like a “reset” than a breakdown, yet momentum can stay weak longer than expected.
• In 2026, the debate shifts from product quality to price paid: competition and market rotation could cap upside.

CrowdStrike Holdings Inc. (NASDAQ: CRWD) stock is up 39% in 2025. It’s had a strong year and has outperformed the broader market. However, like many technology stocks, CrowdStrike has lost momentum in the last quarter, declining 6.6% in the final month. That pullback came despite a strong earnings report in early December, when the company beat on both the top and bottom lines.

CrowdStrike is widely regarded as a “best-in-breed” cybersecurity name. The company has largely shaken off the negative headlines from an outage caused by a software glitch in July 2024—since then CRWD is up about 115%.

Your “birthright claim” just got activated (Ad)

A tiny government task force just wrapped up 20 years of work.

And buried in their federal filings, I found something remarkable:

American citizens now have a legal birthright claim to something previously inaccessible.

Under U.S. law, you can stake your claim right now.The name and ticker are available here now >>>

Still, it’s reasonable to ask whether CRWD will remain an easy trade in 2026. Even after the recent pullback, CrowdStrike trades at roughly 30x sales. That multiple isn’t unheard of for a top-tier cybersecurity company, but it leaves little margin for error.

At this valuation, CrowdStrike must continue to beat expectations—and do so by widening margins—to drive meaningful upside. A slowdown in revenue growth, whether due to execution or broader market conditions, could pressure the stock.

Growth Is Still Strong, Just Not Hypergrowth

Revenue and annual recurring revenue (ARR) are still growing, but at a steadier pace rather than at previous explosive levels. In its most recent quarter, revenue rose 21% year-over-year to $1.23 billion, and ARR grew in the low-30% range, helped by multi-module adoption across the Falcon platform.

Those are excellent metrics for a maturing cybersecurity company. They’re simply not the 40–60% growth rates that drove earlier multiple expansion.

There are a few reasons for the moderation. One may seem counterintuitive: operating leverage is starting to kick in. Adjusted operating margins have moved into the mid-20% range, and free cash flow is scaling as more workloads consolidate on Falcon.

The underlying business is becoming more efficient. If CrowdStrike shifts into a “scale and optimize” phase rather than “hypergrowth at any cost,” long-term investors could be rewarded. But valuation needs to compress, or earnings need to catch up to the stock price—neither outcome is guaranteed.

Competition and Market Rotation: A New Headwind

Competition is another clear headwind. Microsoft’s Defender suite remains the biggest obstacle to pricing power, and Palo Alto Networks (NASDAQ: PANW) continues to bundle aggressively across cloud and endpoint.

If 2026’s market environment favors lower-multiple, cash-generating stocks as rates ease, CrowdStrike could be a tougher trade, particularly in the first half of the year.

How Traders Can Approach CRWD in 2026

CrowdStrike enters 2026 in a corrective phase, trading near $474 and sitting below its 50‑day moving average but still above the 200‑day line—a sign of a pullback within a longer‑term uptrend.

With an RSI near 36 (not shown) and a negative MACD, the stock appears mildly oversold. That setup makes oversold bounces plausible even as short‑term momentum remains weak.

For active traders, this environment tends to favor risk‑defined bullish strategies over outright shorting. The company’s options chain for Jan. 9, 2026, supports that view.

Short‑dated call spreads around the $470–$495 range can target a rebound toward the declining 50‑day moving average while limiting capital at risk. More cautious traders can buy small, out‑of‑the‑money puts to hedge long stock positions or express a tactical bearish view—accepting the premium as the defined maximum loss.

Other ideas include:

• Cash‑secured puts near the $475 strike, where open interest is notable. This lets bullish investors collect premium while potentially entering at a discount if shares drift lower.
• Existing holders can layer covered calls in the $500–$520 band to generate income without capping too much upside. Key risk levels are the $460–$465 support zone and, more decisively, near $450—below that the bullish pullback thesis begins to break down.

Good Company, Tough Trade

CrowdStrike remains best‑in‑breed among cybersecurity providers. The Falcon platform is one of the most comprehensive endpoint and cloud security ecosystems available. Customer retention is strong, ARR is growing, and the balance sheet is healthy.

None of that is in dispute. What is in question is whether investors should continue paying a premium for growth that is gradually normalizing.

For long‑term investors, CrowdStrike is still a name to watch and one to accumulate on deeper pullbacks. For traders or valuation‑sensitive investors, CRWD looks more like a Hold than a Buy heading into 2026. It’s a strong company—just a tough trade at today’s price.

Thank you for subscribing to DividendStocks.com‘s daily newsletter for dividend and income investors that covers ex-dividend stocks, new dividend declarations, dividend stock ideas, and the latest market news.

This email content is a paid advertisement provided by StocksToTrade, a third-party advertiser of DividendStocks.com and MarketBeat. 

If you need assistance with your newsletter, please contact MarketBeat’s U.S. based support team at contact@marketbeat.com.

If you no longer wish to receive email from DividendStocks.com, you can unsubscribe.

© 2006-2026 MarketBeat Media, LLC. All rights protected.
345 North Reid Place, Suite 620, Sioux Falls, SD 57103-7078. U.S.A..

Today’s Featured Content: BRICS Push to Kill Dollar—Gold Eyes $6,000 Next (From Americas Gold Company)

Creating the Winners and Losers

Delivering World-Class Financial Research Since 1999The latest stock-moving White House policies… Defense spending could jump more than 70%… Limits on investment properties… An AI red flag to watch in 2026… Stansberry Investor Hour: Your job vs. AI…It’s a familiar story…As we look ahead to 2026 – and years beyond – you can bet on one thing with near certainty: more government spending…Late yesterday, President Donald Trump went to Truth Social and announced the latest example: an extra half-trillion dollars for U.S. military spending in 2027. His post on the Truth Social platform read…After the long and difficult negotiations with Senators, Congressmen, Secretaries, and other Political Representatives, I have determined that, for the Good of our Country, especially in these very troubled and dangerous times, our Military Budget for the year 2027 should not be $1 Trillion Dollars, rather $1.5 Trillion Dollars…That’s a 70%-plus increase over the 2025 defense budget. He added, “This will allow us to build the ‘Dream Military’ that we have long been entitled to, and, more importantly, that will keep us SAFE and SECURE, regardless of foe.”Today, the news also sent shares of U.S. defense stocks higher. Lockheed Martin (LMT) was up about 4% and Northrop Grumman (NOC) was 2% higher, among other gainers in the industry. They’ve become the latest “winners” tied to recently dictated White House policy.And here’s maybe a group of ‘losers’…Earlier yesterday, Trump said he’s looking to limit institutional buying of single-family homes – a long-discussed trend contributing to tight housing supply and rising home prices. Specifically, Trump wrote (again) on Truth Social…I am immediately taking steps to ban large institutional investors from buying more single-family homes, and I will be calling on Congress to codify it. People live in homes, not corporations.It’s hard to know for sure what will constitute “large” or how limits would be implemented. But some real estate investment trusts (“REITs”) and investing firms like Blackstone (BX) have significant holdings of single-family homes and apartments.Shares of Blackstone fell more than 5% yesterday… And Invitation Homes (INVH), the largest renter of single-family homes in the U.S., saw its shares drop 6%. (Both were up around 1% today.)Companies like these have become increasingly influential in the residential market in certain cities and regions. Nationally, investors were fewer than 20% of America’s homebuyers in 2019, yet they neared 30% last year.And in a November report, Realtor.com found that institutional investors are paying up to 35% above the median home sales price. So they’re outbidding individual homebuyers and keeping a floor on home prices.Of course, real estate is local, so this behavior affects some parts of the country more than others. In Atlanta, Georgia and Jacksonville, Florida, for instance, institutional investors own more than 20% of the single-family rental market.Trump isn’t proposing that firms would have to sell their existing housing portfolios. But they’d have to stop buying more.Moving on, we’re also watching the AI story in 2026…Just like last year, we’re willing to bet that AI remains at the forefront of investors’ minds in 2026. This will include the Magnificent Seven stocks’ capital expenditures (“capex”), along with potential AI startups’ initial public offerings (“IPOs”).Things look fine for AI now, but that doesn’t mean this boom is devoid of any cracks…Last year, we highlighted that Oracle (ORCL) could be the “canary in the AI coal mine.”Put simply, Oracle has weaker financials than some of the other Big Tech firms – like Alphabet (GOOGL) and Microsoft (MSFT) – but it’s trying to keep up with them in AI spending plans.Investors aren’t so sure. And Oracle stock is down more than 40% from its all-time high in September.Over the weekend, we saw another potential red flag in AI…Don Johnson, chief economist at the research firm MacroEdge, shared the below chart and this post on the social platform X…If Johnson’s projections for 100 more cancellations or postponements in the next six months are realized, it will be bad news for the AI boom…This year alone, Goldman Sachs estimates that hyperscalers will spend $539 billion in capex – up 35% from the $398 billion they spent in 2025. But the only way that spending makes sense is if the companies think these investments will eventually be profitable.And if they’re pulling back on building out data centers for their AI goals, it could indicate that they’re rethinking the usefulness of AI. That could be what eventually pops the AI bubble down the road.For now, the bulls are in control…This week, at the CES electronics show, tech companies are showing off their latest innovations. AI is everywhere.So far, we’ve seen a humanoid factory robot from Boston Dynamics (which was also highlighted on 60 Minutes on Sunday)… an AI assistant to help folks operate and maintain equipment from Caterpillar (CAT)… and even plans for an Nvidia (NVDA) self-driving car in a partnership with Mercedes.(The Associated Press recapped some of the “coolest” things from Day 1 of the conference here. One highlight is a lollipop that plays music while you eat it, using something called “bone induction technology.”)Of course, there’s been a lot more than that. And AI darlings – like Nvidia and Advanced Micro Devices (AMD) – have even used their platforms this week to talk about the broader AI landscape. Starting with Nvidia…The leading AI chipmaker unveiled its newest AI platform, called the Rubin platform. Rubin is made up of six of its next-generation chips and will cut down on the cost and time it takes to train AI models, the company said.And it couldn’t come at a better time, according to CEO Jensen Huang. As he said in a statement…AI computing demand for both training and inference is going through the roof.AMD CEO Lisa Su said more of the same…In an interview with Bloomberg News on Tuesday, Su said that “AI is not just hype.” She added that computing power will have to increase 100-fold over the next five years to meet AI demand. And that means we’re still in the “early innings” of AI, according to Su.If these dominant AI chipmakers are correct, it sounds like any “cracks” that we described above will continue to be small for now.In last week’s Stansberry Investor Hour, GAI Insights’ Dr. John Sviokla joined the show for a fascinating discussion on AI, the parts of the industry that make worthy investments, and how you can keep a job in an AI world…Click here to watch our entire interview on our YouTube page… or listen to the audio version on our website or wherever you listen to podcasts, like Apple Podcasts, Spotify, or Audible. Just search “Stansberry Investor Hour” and subscribe to get more episodes when they go live.Recommended Links:AIRING NOW: Critical Update to 2026 Crash PredictionIn a viral broadcast seen by at least 2 million people, investing icon Marc Chaikin shared a 2026 crash prediction that was based on 100 years of stock market data. And now that 2026 is here, he just released a broadcast from his home in Connecticut to explain what to expect… share his battle plan… along with the top stocks to BUY and SELL immediately. Click here to tune in now (includes two free stock recommendations).The $20 Move Giving You Exposure to 2 Ounces of Pure Gold (Worth Around $9,000 Today)An ex-Goldman Sachs vice president reveals a secret of the rich and connected that lets you tap into the upside of a huge amount of real, physical gold for just about $20 at a time. He says the future upside could be 1,000%. Even a relatively small amount of money could go a long way when every $20 or so leverages the upside in 2 ounces of pure gold, as he’ll explain. See this $20 “gold hack” right here.New 52-week highs (as of 1/7/26): ProShares Ultra Nasdaq Biotechnology (BIB), Alpha Architect 1-3 Month Box Fund (BOXX), Ciena (CIEN), WisdomTree Japan SmallCap Dividend Fund (DFJ), Enel (ENLAY), Cambria Emerging Shareholder Yield Fund (EYLD), Fanuc (FANUY), FirstCash (FCFS), Comfort Systems USA (FIX), Genmab (GMAB), iShares Biotechnology Fund (IBB), Ideaya Biosciences (IDYA), Illumina (ILMN), IQVIA (IQV), Kinross Gold (KGC), New York Times (NYT), Invesco Oil & Gas Services Fund (PXJ), Roche (RHHBY), ProShares Ultra Health Care (RXL), Vale (VALE), and State Street Health Care Select Sector SPDR Fund (XLV).In today’s mailbag, feedback on yesterday’s Digest that discussed investment in nuclear energy… Do you have a comment or question? As always, e-mail us at feedback@stansberryresearch.com.“Hi folks, Nuclear sounds great in so many ways but I didn’t see anything written about how to dispose of the waste. This stuff is going to be toxic for millennia, long after our civilization is gone. Not the sort of thing we want to be leaving for our descendants far down the line. Just wanted to bring that up.” – Subscriber Charlie L.All the best,Corey McLaughlin and Nick Koziol Baltimore, Maryland January 8, 2026Stansberry Research Top 10 Open RecommendationsTop 10 highest-returning open stock positions across all Stansberry Research portfolios. Returns represent the total return from the initial recommendation.InvestmentBuy DateReturnPublicationAnalystMSFT Microsoft02/10/121,559.3%Stansberry’s Investment AdvisoryPorterMSFT Microsoft11/11/101,501.2%Retirement MillionaireDocADP Automatic Data Processing10/09/08975.1%Extreme ValueFerrisBRK.B Berkshire Hathaway04/01/09786.4%Retirement MillionaireDocGOOGL Alphabet12/15/16693.3%Retirement MillionaireDocWRB W.R. Berkley03/15/12634.9%Stansberry’s Investment AdvisoryPorterALS-T Altius Minerals03/26/09556.0%Extreme ValueFerrisCIEN Ciena10/20/22534.1%Stansberry Innovations ReportEngelAXP American Express08/04/16521.4%Stansberry’s Investment AdvisoryPorterAFG American Financial10/11/12494.6%Stansberry’s Investment AdvisoryPorterPlease note: Securities appearing in the Top 10 are not necessarily recommended buys at current prices. The list reflects the best-performing positions currently in the model portfolio of any Stansberry Research publication. The buy date reflects when the editor recommended the investment in the listed publication, and the return shows its performance since that date. To learn if a security is still a recommended buy today, you must be a subscriber to that publication and refer to the most recent portfolio.Top 10 Totals4Stansberry’s Investment AdvisoryPorter3Retirement MillionaireDoc2Extreme ValueFerris1Stansberry Innovations ReportEngelTop 5 Crypto Capital Open RecommendationsTop 5 highest-returning open positions in the Crypto Capital model portfolioInvestmentBuy DateReturnPublicationAnalystWSTETH/USD Wrapped Staked Ethereum12/07/182,411.1%Crypto CapitalWadeBTC/USD Bitcoin11/27/182,328.1%Crypto CapitalWadeONE/USD Harmony12/16/191,032.3%Crypto CapitalWadeQRL/USD Quantum Resistant Ledger01/19/21960.4%Crypto CapitalWadePOL/USD Polygon02/26/21651.0%Crypto CapitalWadePlease note: Securities appearing in the Top 5 are not necessarily recommended buys at current prices. The list reflects the best-performing positions currently in the Crypto Capital model portfolio. The buy date reflects when the recommendation was made, and the return shows its performance since that date. To learn if it’s still a recommended buy today, you must be a subscriber and refer to the most recent portfolio.Stansberry Research Hall of FameTop 10 all-time, highest-returning closed positions across all Stansberry portfoliosInvestmentDurationGainPublicationAnalystNvidia (NVDA)^*5.96 years1,466%Venture Tech.LashmetMicrosoft (MSFT)^12.74 years1,185%Retirement MillionaireDocInovio Pharma. (INO)^1.01 years1,139%Venture Tech.LashmetRocket Lab (RKLB)^2.35 years1,034%Venture Tech.LashmetSeabridge Gold (SA)^4.20 years995%Sjug Conf.SjuggerudBerkshire Hathaway (BRK-B)^16.13 years800%Retirement MillionaireDocIntellia Therapeutics (NTLA)1.95 years775%Amer. MoonshotsRootRite Aid 8.5% bond4.97 years773%True IncomeWilliamsPNC Warrants (PNC-WS)6.16 years706%True Wealth SystemsSjuggerudMaxar Technologies (MAXR)^1.90 years691%Venture Tech.Lashmet^ These gains occurred with a partial position in the respective stocks. * Editor Dave Lashmet closed the first leg of this Nvidia position in November 2016 for a gain of about 108%. Then, he closed the second leg in July 2020 for a 777% return. And finally, in May 2022, he booked a 1,466% return on the final leg. Subscribers who followed his advice on Nvidia could’ve recorded a total weighted average gain of more than 600%.Stansberry Research Crypto Hall of FameTop 5 highest-returning closed positions in the Crypto Capital model portfolioInvestmentDurationGainPublicationAnalystBand Protocol (BAND)0.31 years1,169%Crypto CapitalWadeTerra (LUNA)0.41 years1,166%Crypto CapitalWadePolymesh (POLYX)3.84 years1,157%Crypto CapitalWadeFrontier (FRONT)0.09 years979%Crypto CapitalWadeBinance Coin (BNB)1.78 years963%Crypto CapitalWadeYou have received this e-mail as part of your subscription to Stansberry Digest. If you no longer want to receive e-mails from Stansberry Digest click here.Published by Stansberry Research.You’re receiving this e-mail at pahovis@aol.com. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberryresearch.com. Please note: The law prohibits us from giving personalized financial advice.© 2026 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 or stansberryresearch.com.Any brokers mentioned constitute a partial list of available brokers and is for your information only. Stansberry Research does not recommend or endorse any brokers, dealers, or investment advisors.Stansberry Research forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Stansberry Research (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation.This work is based on SEC filings, current events, interviews, corporate press releases, and what we’ve learned as financial journalists. It may contain errors, and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility.

The 2026 Investing Landscape

Delivering World-Class Financial Research Since 1999What the market can and can’t see… AI, satellites, gold, and mortgages… A new AI energy crisis… A critical metal set to soar… The ‘bullet to the brain’ theory… Big changes, big opportunities…2026 isn’t going to be quite like 2025…Regular readers know I don’t make predictions. So talking about what will happen this year might sound weird coming from me.But I’m talking about the 2026 investing landscape as it looks right now…While some 2025 trends might continue this year, many of the year’s top stocks likely won’t perform anywhere near as well in 2026. You see, the excitement is already baked into their stock prices.By “baked into the market,” I’m talking about stocks like Palantir Technologies (PLTR). It’s a great business… but the stock has already soared more than 600% over the past five years and trades at more than 400 times earnings. The cat is out of the bag, and there’s likely far more downside than upside at this point.I’d much rather find the stocks that are where Palantir was five years ago – the ones ready to make an epic, multibagger run and maybe even explode higher this year as the market begins to see their potential.Let me explain by talking about some specific companies. First, let’s look at the stocks that outperformed last year…According to data compiled by Bloomberg, the following companies were the top 10 performing stocks for 2025 that currently have a $20 billion-plus market cap:With the artificial-intelligence (“AI”) boom ramping up last year, of course several AI-related stocks made the list.Lumentum (LITE) supplies optical connectivity components that help link graphics processing units – the beating heart of AI infrastructure – together. Western Digital (WDC) and Seagate Technology (STX) make hard disk and solid-state drives for data storage. Micron (MU) makes high-performance memory chips. Bloom Energy (BE) makes fuel cells – the sort of onsite power generation that data centers desperately need.So far, 2026 has started off by resembling 2025. Since the first of the year, Micron is the No. 1-performing stock above $50 billion in market cap, with Western and Seagate among the top seven.Still, I find it hard to believe those stocks will perform anywhere near as well this year as they did in 2025. The AI boom trend is already baked into the big winners listed above and many others… but not all of them.As we’ll discuss in a moment, AI is still evolving and creating all kinds of opportunities. As I’ve said before, like the Internet, AI will leave no business or investor untouched.Investors were also excited about satellites last year…AST SpaceMobile (ASTS) and EchoStar (SATS) are plays on the buildout of satellite connectivity.AST builds satellites. But putting satellites in space is a highly capital-intensive affair. AST continues to burn through cash and needs to keep launching more satellites. To justify its epic 2025 performance, it will have to start generating a lot more revenue and prove itself as a business. That’s probably further out in the future than one year, so I figure there’s limited – if any – upside left in the stock… and too much downside.EchoStar is more interesting to me… It transformed itself from a debt-laden, near-bankruptcy firm to a cash-rich success story by selling wireless spectrum to AT&T and SpaceX, with the latter granting EchoStar a large equity stake.EchoStar’s deal with AT&T and SpaceX was potentially very smart because it transitioned the company away from the capital-intensive satellite constellation business to an asset-light business model focused on its Boost Mobile, DISH TV, Sling TV, and Hughes brands. The words “asset-light” are always worth at least a few minutes of my time… and often a whole lot more. I don’t pretend to know how any stock will perform this year, and EchoStar has had a great run already… but its business is much more interesting to me as a longer-term investment than AST’s.Next, we have gold and mortgages…Gold rose roughly 65% in 2025 which sent gold miners like AngloGold Ashanti (AU) soaring. I must admit, contrarian though I may be, I expect gold to keep rising this year – even after its blistering run in 2025 – and I view it as a good longer-term bet. That’s why I’m staying long gold stocks in both The Ferris Report and Extreme Value.Government-sponsored mortgage firms Fannie Mae (FNMA) and Freddie Mac (FMCC) were put under government conservatorship after the financial crisis blew up the housing and mortgage industries in 2008. So it might sound surprising to find them on the top-performing list for 2025.The two stocks soared amidst the belief that President Donald Trump’s administration would end their conservatorship and privatize them. Hedge-fund mogul Bill Ackman has led the charge on these two stocks, believing that privatizing them will unlock massive value.Frannie Mae and Freddie Mac show the confidence folks have in the Trump administration’s ability to move the needle in the industries it favors. In my December 19 Digest, I made it clear that this will become a major trend over the next year or more.Ackman thinks Fannie and Freddie could each trade in the $40s. Today, they’re around $10 to $11 per share. If Ackman is right, there’s a lot more upside left in these stocks, even though they’ve already done very well.All of this leads me to the question…What isn’t already baked into the market for 2026?…Said another way, what stocks look like they’re about to perform a lot better this year than last?In the December issue of The Ferris Report, I offered one answer to that question: an energy crisis nobody’s talking about.The crisis centers around data centers’ unique power needs, and what I expect to happen if the power grid shuts down for 48 hours or more in key areas like Northern Virginia, Atlanta, Seattle, and other places with lots of data centers.I can’t give too much away out of fairness to Ferris Report subscribers, but I recommended two stocks that provide critical energy products for data centers. I believe these names will do well even if I’m wrong about a coming crisis… and they’ll soar if I’m right.These stocks have underperformed the S&P 500 Index over the past couple of years, so there’s plenty of upside potential. This energy crisis and its solution is my biggest new idea for 2026.Ferris Report subscribers can find the December issue right here. And if you don’t already have a subscription to The Ferris Report, you can learn more here.Overall, energy is a big bottleneck for data centers…Because of the massive amount of energy data centers need, builders are becoming more interested in generating their own power. They can build their own power plants faster than they can get connected to the energy grid in many instances.For example, it can take seven years or more to get a new grid connection in Northern Virginia – which has the highest concentration of data centers in the world. But it’s possible to build new on-site power generation in half that time.Natural gas will likely become an important energy source for these centers in 2026. It’s considered the cleanest burning fossil fuel, and it’s widely available in the U.S.The new uptime standard for data centers is 99.999%. In short, these services can be down for no more than five minutes and 26 seconds per year. Renewable sources simply aren’t reliable enough to fulfill that mission as primary or backup power.Natural gas was volatile (as always) in 2025, but overall, it rose around 1.5% for the year. But that’s not the whole story. From its lowest levels in 2023 to its highest prices last year, it rose as much as 234%.Natural gas giant EQT (EQT) has risen more than 50% (including dividends) since my March 2024 Ferris Report recommendation, compared with a 32% rise in the S&P 500 during the same period.So natural gas demand seems to be baked into the market. But I don’t think the trend has run its course yet. That’s why we’re staying long on EQT in The Ferris Report. If the crisis I expect in data-center power happens this year, I expect EQT and other gas stocks to benefit.The data-center energy bottleneck isn’t just about fuel…It’s about gas turbines, too. It takes a lot of investment, time, and manufacturing capacity to build these big, complex gas turbines.GE Vernova (GEV), Siemens (SIEGY), and Mitsubishi Heavy Industries (MHVYF) account for about two-thirds of global turbine-making capacity. All three have big order backlogs stretching years into the future.That’s why all three of their stocks have outperformed the S&P 500 over the past couple of years. The backlogs are well known, unlike the impending energy crisis I wrote about last month in The Ferris Report. This part of the equation is well known and appears to be priced into the market.Nuclear power generation and uranium stocks have also benefited from the AI energy trend. So perhaps I should add them to the baked-in list. But you never know how far a trend will go, and I believe we’re in the midst of a longer-term bull market throughout the energy complex. It’ll be volatile, but I think there’s more upside ahead.Another trend that did well last year but hasn’t yet run its course is in one of the most important metals…And I’m not talking about silver or gold…A world that runs on electricity also runs on copper, making it perhaps the most important of all the base metals. Copper is used in construction, cars (especially electric vehicles), computers, every electric device you can name, and data centers. Everywhere there’s electricity, there’s copper.While volatile throughout the year, copper rose 41% in 2025… propelling copper stocks higher. The copper stock in our Extreme Value Ultimate Commodity Hypercycle Portfolio (exclusive for Premier subscribers) rose 63% last year for a total return of 112% since our March 2023 recommendation.But I suspect there’s more upside in copper and copper stocks from here…Right now, copper sells for around $5.80 per pound. I would guess the price that incentivizes new copper mining capacity is somewhere between $5.50 and $6.50 per pound.But as the very smart folks at Newfoundland-based royalty company Altius Minerals (ALS.TO) taught me a few years ago, the market doesn’t instantly respond once that price is reached.Their research shows that folks who finance new mines usually require double the incentivization price before they throw big amounts of capital into building new supply. That’s $11 to $13 per pound of copper. Whether it takes one year to get there or five, if copper goes that high, copper stocks will soar.In other words, there’s good reason to expect further upside in copper and copper equities.After I looked at the biggest gainers of 2025, I couldn’t help wondering about the year’s big losers…According to data compiled by Bloomberg, seven U.S.-traded stocks with a current market cap of $10 billion-plus fell 40% or more last year:I won’t go through them all, but Gartner (IT) appears to be a victim of AI. Though the company has positioned itself as “the world authority on AI,” the market seems to believe its insight and advice can be replaced by AI.Overall, as I look at the list of losers, I’m reminded of something I heard many years ago at a Grant’s Interest Rate Observer conference in New York.One of the speakers was discussing what stocks his firm likes to sell short. He said they didn’t want to short companies with lots of niggling problems because they could probably be fixed with proper management.He preferred to short a stock with “one bullet to the brain” – a single problem that would destroy its business, which didn’t appear to be fixable by management.It’s a decent way to begin assessing this list of losers as potential contrarian buys or even as shorts. Stocks down this much are usually getting whacked for a good reason. If the reason is one big bullet to the head, there could be plenty more downside ahead. If not, maybe they’re good contrarian longs.The bullet to the head theory is also interesting because it’s the flip side of something legendary investor Warren Buffett wrote in his 1989 shareholder letter:[A] great investment opportunity occurs when a marvelous business encounters a one-time huge, but solvable, problem as was the case many years back at both American Express and GEICO.Figuring out if a big problem is a bullet to the head or solvable is a big job. But if you get it right, there’s probably a big return in it for you.However, it’s worth noting the next sentence Buffett wrote in the 1989 letter…‘Overall, however, we’ve done better by avoiding dragons than by slaying them…’Amen to that. In both Extreme Value and The Ferris Report, we focus on businesses that are running well and aren’t beset by big problems.That said, Fiserv (FISV) seems like it’s worth thinking about…Fiserv provides software for banks that facilitates online banking, online bill pay, and debit, credit, ATM, and prepaid card processing. The business is deeply embedded in the financial infrastructure.Fiserv has been valued like a “marvelous business” for years. But its stock fell nearly 50% in three trading sessions in October after it issued a disappointing third-quarter earnings report, drastically cut earnings guidance, and admitted that it had been underinvesting in the business and charging too much for its services.Now, Fiserv is mired in a turnaround that’s expected to take multiple quarters. It’ll have to invest heavily and work hard to satisfy customers.At least, that’s the popular narrative. Another way to look at it is that the new CEO gets to start out with a drastically lower stock price, providing him with plenty of upside potential. And he can blame the company’s problems on previous management, giving him more leeway to right the ship.For now, none of Fiserv’s problems seem like a bullet to the brain. Whether it’ll recover to a much higher valuation is another question.This isn’t a recommendation. It’s just an example of how I’ll be thinking about these stocks as I assess each one for a possible recommendation.It’s also a way of saying that I won’t be taking anything for granted in 2026. AI has changed the landscape for businesses, giving me reason to go back and look at a wide variety of stocks from a whole new perspective.In short, 2026 is setting up to be an exciting year. While some trends will surely continue, we’re also seeing big technological changes… potential crises… and massive new opportunities.Get Ready for an Upgraded StansberryResearch.comSoon, it will be easier than ever to find and evaluate investment ideas.We’re revamping StansberryResearch.com to better serve you – with the changes slated to take effect in a few weeks. You’ll continue to log in with the same username and password, and, of course, you’ll enjoy full access to everything you do now… plus much more.Our tech and design team has redesigned our site for easier navigation, quicker research, and to highlight new ways for you to generate ideas and research stocks.Keep your eye on your inbox – we’ll share more details as we get closer…Recommended Links:Here’s What You MissedA 50-year Wall Street veteran – who called the COVID-19 crash, the 2022 bear market, and the 2023 bank panic – says a rare January “trigger” could determine whether 2026 is a wealth-building year for you or a devastating setback. It has 100% accuracy since 1950. Click here now for the full story(and TWO free stock recommendations).Executive Order 14318: The Most Important Document You’ve Never ReadThe mainstream media just missed the biggest financial story of the year… President Donald Trump signed an executive order to start unlocking an estimated $5.1 trillion in federal assets for the benefit of every American citizen. Most Americans have no idea this opportunity exists… But according to a former Trump adviser, it could trigger a historic “gold rush” for the American people. See what the media missed.New 52-week highs (as of 1/8/26): Agnico Eagle Mines (AEM), Atmus Filtration Technologies (ATMU), Alpha Architect 1-3 Month Box Fund (BOXX), Pacer U.S. Cash Cows 100 Fund (COWZ), WisdomTree Japan SmallCap Dividend Fund (DFJ), Enel (ENLAY), iShares MSCI Germany Fund (EWG), Expeditors International of Washington (EXPD), Cambria Emerging Shareholder Yield Fund (EYLD), Franco-Nevada (FNV), Cambria Foreign Shareholder Yield Fund (FYLD), Alphabet (GOOGL), iRhythm Technologies (IRTC), Kinross Gold (KGC), L3Harris Technologies (LHX), Mueller Industries (MLI), Merck (MRK), New Gold (NGD), New York Times (NYT), Invesco Oil & Gas Services Fund (PXJ), Snap-on (SNA), and Valero Energy (VLO).In today’s mailbag, thoughts on our description of Nicolás Maduro from earlier this week… Do you have a comment or question? As always, e-mail us at feedback@stansberryresearch.com.“Happy New Year Corey. In your January 5th Digest you referred to the U.S. action in Venezuela as ‘Taking out a president’, and then [Tuesday] nightyou referred to Maduro as the ‘now-former Venezuelan President’. When you refer to him as the ‘president’ or the former ‘President’, upon which election do you consider him as having earned the title of President of Venezuela? I’m no expert, but my recollection was that he claimed to be the president after a 2018 election but: a) Venezuela’s legislature voted to declare the claimed election victory illegitimate; and b) the U.S. and many other countries refused to recognize him as the president. If I’m right, it is possible some of your readers may be inclined to believe the narrative that suggests President Trump took out a legitimately elected leader of a foreign country (which I do not think is accurate).”Keep up the good work and God bless.” – Subscriber Scott P.Corey McLaughlin comment: I get your points, but in telling what happened and naming Maduro, we were less interested in being the arbiter of the legitimacy of a presidency and Trump’s decision than we are discussing the economic impacts of Maduro no longer being the head of the country… which is what he was, and called himself, at least.Good investing,Dan Ferris Medford, Oregon January 9, 2026Stansberry Research Top 10 Open RecommendationsTop 10 highest-returning open stock positions across all Stansberry Research portfolios. Returns represent the total return from the initial recommendation.InvestmentBuy DateReturnPublicationAnalystMSFT Microsoft02/10/121,541.9%Stansberry’s Investment AdvisoryPorterMSFT Microsoft11/11/101,491.1%Retirement MillionaireDocADP Automatic Data Processing10/09/08989.5%Extreme ValueFerrisBRK.B Berkshire Hathaway04/01/09789.6%Retirement MillionaireDocGOOGL Alphabet12/15/16701.7%Retirement MillionaireDocWRB W.R. Berkley03/15/12651.4%Stansberry’s Investment AdvisoryPorterALS-T Altius Minerals03/26/09553.6%Extreme ValueFerrisAXP American Express08/04/16528.8%Stansberry’s Investment AdvisoryPorterAFG American Financial10/11/12499.3%Stansberry’s Investment AdvisoryPorterHSY Hershey12/07/07477.0%Stansberry’s Investment AdvisoryPorterPlease note: Securities appearing in the Top 10 are not necessarily recommended buys at current prices. The list reflects the best-performing positions currently in the model portfolio of any Stansberry Research publication. The buy date reflects when the editor recommended the investment in the listed publication, and the return shows its performance since that date. To learn if a security is still a recommended buy today, you must be a subscriber to that publication and refer to the most recent portfolio. Top 10 Totals5Stansberry’s Investment AdvisoryPorter3Retirement MillionaireDoc2Extreme ValueFerris Top 5 Crypto Capital Open RecommendationsTop 5 highest-returning open positions in the Crypto Capital model portfolioInvestmentBuy DateReturnPublicationAnalystWSTETH/USD Wrapped Staked Ethereum12/07/182,372.7%Crypto CapitalWadeBTC/USD Bitcoin11/27/182,320.8%Crypto CapitalWadeONE/USD Harmony12/16/191,031.7%Crypto CapitalWadeQRL/USD Quantum Resistant Ledger01/19/21987.3%Crypto CapitalWadePOL/USD Polygon02/26/21653.2%Crypto CapitalWadePlease note: Securities appearing in the Top 5 are not necessarily recommended buys at current prices. The list reflects the best-performing positions currently in the Crypto Capital model portfolio. The buy date reflects when the recommendation was made, and the return shows its performance since that date. To learn if it’s still a recommended buy today, you must be a subscriber and refer to the most recent portfolio. Stansberry Research Hall of FameTop 10 all-time, highest-returning closed positions across all Stansberry portfoliosInvestmentDurationGainPublicationAnalystNvidia (NVDA)^*5.96 years1,466%Venture Tech.LashmetMicrosoft (MSFT)^12.74 years1,185%Retirement MillionaireDocInovio Pharma. (INO)^1.01 years1,139%Venture Tech.LashmetRocket Lab (RKLB)^2.35 years1,034%Venture Tech.LashmetSeabridge Gold (SA)^4.20 years995%Sjug Conf.SjuggerudBerkshire Hathaway (BRK-B)^16.13 years800%Retirement MillionaireDocIntellia Therapeutics (NTLA)1.95 years775%Amer. MoonshotsRootRite Aid 8.5% bond4.97 years773%True IncomeWilliamsPNC Warrants (PNC-WS)6.16 years706%True Wealth SystemsSjuggerudMaxar Technologies (MAXR)^1.90 years691%Venture Tech.Lashmet^ These gains occurred with a partial position in the respective stocks. * Editor Dave Lashmet closed the first leg of this Nvidia position in November 2016 for a gain of about 108%. Then, he closed the second leg in July 2020 for a 777% return. And finally, in May 2022, he booked a 1,466% return on the final leg. Subscribers who followed his advice on Nvidia could’ve recorded a total weighted average gain of more than 600%. Stansberry Research Crypto Hall of FameTop 5 highest-returning closed positions in the Crypto Capital model portfolioInvestmentDurationGainPublicationAnalystBand Protocol (BAND)0.31 years1,169%Crypto CapitalWadeTerra (LUNA)0.41 years1,166%Crypto CapitalWadePolymesh (POLYX)3.84 years1,157%Crypto CapitalWadeFrontier (FRONT)0.09 years979%Crypto CapitalWadeBinance Coin (BNB)1.78 years963%Crypto CapitalWade You have received this e-mail as part of your subscription to Stansberry Digest. If you no longer want to receive e-mails from Stansberry Digest click here.Published by Stansberry Research.You’re receiving this e-mail at pahovis@aol.com. Stansberry Research welcomes comments or suggestions at feedback@stansberryresearch.com. This address is for feedback only. For questions about your account or to speak with customer service, call 888-261-2693 (U.S.) or 443-839-0986 (international) Monday-Friday, 9 a.m.-5 p.m. Eastern time. Or e-mail info@stansberryresearch.com. Please note: The law prohibits us from giving personalized financial advice.© 2026 Stansberry Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Stansberry Research, 1125 N Charles St, Baltimore, MD 21201 or stansberryresearch.com.Any brokers mentioned constitute a partial list of available brokers and is for your information only. Stansberry Research does not recommend or endorse any brokers, dealers, or investment advisors.Stansberry Research forbids its writers from having a financial interest in any security they recommend to our subscribers. All employees of Stansberry Research (and affiliated companies) must wait 24 hours after an investment recommendation is published online – or 72 hours after a direct mail publication is sent – before acting on that recommendation.This work is based on SEC filings, current events, interviews, corporate press releases, and what we’ve learned as financial journalists. It may contain errors, and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility.

Innoviva’s Nuzolvence Boosts Biotech Momentum

UnsubscribeDouble-digit gains from wilds stock swings (From Brownstone Research)Biotech Is Heating Up—These 2 Red-Hot Stocks Stand OutWritten by Nathan Reiff on January 8, 2026 At a GlanceBiotech names tend to spike on exciting drug approvals and clinical trial data, though these firms are highly volatile and can be risky as well.Two key FDA updates for Axsome could further boost revenue, which has already climbed by nearly two-thirds year-over-year in the latest quarter.Innoviva’s Nuzolvence meets a significant need in the treatment of a condition affecting 82 million globally each year.Biotech companies provide the medical innovations and technological breakthroughs that improve healthcare and can achieve tremendous financial results in the process. However, these names also tend to be highly volatile as a result of the difficult and complex process associated with drug and medical device development as well as the hard-to-navigate regulatory environment. Still, investors look to companies with strong pipelines or exciting projects in progress for a hint about which biotech names may stand out in the months or quarters to come.Two biotech names in particular—Axsome Therapeutics Inc. (NASDAQ: AXSM)and Innoviva Inc. (NASDAQ: INVA)—may draw particular attention from investors at the start of 2026. Each of these companies has potentially transformational products in various stages of development. Although nothing is guaranteed, these standouts might be worth watching this year.The Market Reset Is Coming—Here’s How to Read It Early (Ad)See Early-Stage Activity Before It Reaches Mainstream Screens We highlight micro-cap and small-cap companies gaining early traction based on research, visibility shifts, and market interest.Get the Free Guide — Join Now2 Major FDA Updates Boost Axsome’s Standing in the New YearAxsome develops small-molecule drugs for central nervous system disorders including fibromyalgia, migraine, and more. The company is a popular biotech name at the start of 2026 thanks in large part to key regulatory updates announced at the very end of 2025. The FDA accepted for filing in December a supplemental New Drug Application for Axsome’s oral investigational therapy AXS-05 for the treatment of agitation associated with Alzheimer’s. The drug is already approved for the treatment of major depressive disorder.Given that about three-quarters of Alzheimer’s patients experience agitation, the potential market for this application of AXS-05 is significant. However, it’s not Axsome’s only positive development heading into the new year. The FDA also signaled support for a New Drug Application filing for the company’s AXS-12 for narcolepsy applications based on prior data.Axsome’s late-stage pipeline is thus very strong, and expanding indications across these and other drugs would open up significant new revenue streams. The company’s product revenue is already strong, having climbed 63% year-over-year (YOY) in the latest quarterand helping to narrow net losses. However, cash-flow positivity is still elusive, and margin pressures are lingering, so investors should be aware of these risks.Wall Street is exceedingly bullish when it comes to Axsome shares, as 19 out of 20 analysts have rated the stock a Buy. A flurry of reiterated ratings started the year, including from Needham & Co., Guggenheim, Oppenheimer, and Cowen. Collectively, analysts see shares rising more than 8% to over $188 each.Approval of Nuzolvence May Be Transformational for InnovivaInnoviva’s approach is somewhat different from traditional biopharma names in that it primarily acquires and monetizes royalty interests in drugs, rather than develop them in-house. The company’s particular focus has been on inhaled respiratory therapies.In December, the FDA approved Innoviva’s Nuzolvence, a first-in-class, single-dose oral antibiotic to treat gonorrhea. The drug is the first approved alternative to an injectable treatment which was the only available option previously. Gonorrhea is one of the most prevalent sexually transmitted infections, with close to 1 million cases annually in the United States and 82 million around the world. As a result, Innoviva’s new treatment option has a massive potential market and little by way of competition. It also stands out as gonorrhea has developed resistance to many existing antibiotics.The success of Nuzolvence highlights a win for Innoviva Specialty Therapeutics, a unit of the broader company that develops and commercializes its own therapies. This could point the company toward continued internal development of new drug candidates rather than a primary focus on royalties of externally developed treatments.Innoviva’s financials have already been strong in multiple respects, even prior to the FDA’s approval and the impending launch of Nuzolvence this year. The company beat on both earnings per share (EPS) and revenue estimates in the latest quarterly report, with total revenue climbing by 20% YOY to nearly $108 million on strong product sales on products like Giapreza and Xacduro. Zevtera, a specialized antibiotic for certain types of bloodstream infections and bacterial pneumonia, was launched in July 2025 and is likely to continue ramping up sales heading into the first quarter of this year.A majority of analysts view INVA shares optimistically, and the company’s consensus price target is $38.80, nearly double where it is trading at the start of the year. With sales expected to increase as Nuzolvence launches and Zevtera takes off, this target may well be within reach.Read this article online ›Featured Stories3 Stocks With Analyst Revisions That Could Drive Earnings SurprisesBig gains from crazy market swings? (From Brownstone Research)Higher-for-Longer Rates Could Reward These 3 Overlooked StocksNo AI Bots. Just Real Signals. (From Market Pulse Today)3 of the Most Important Charts to Watch Right NowRocket Lab’s Rally Isn’t Random—Big Catalysts Are AheadSable Offshore: The Court Ruling That Changes Everything  Did you enjoy this article?     Thank you for subscribing to DividendStocks.com‘s daily newsletter for dividend and income investors that covers ex-dividend stocks, new dividend declarations, dividend stock ideas, and the latest market news. If you have questions about your account, please don’t hesitate to email MarketBeat’s U.S. based support team at contact@marketbeat.com. If you no longer wish to receive email from DividendStocks.com, you can unsubscribe. © 2006-2026 MarketBeat Media, LLC.  345 N Reid Pl. #620, Sioux Falls, SD 57103-7078. USA..Further Reading: The last gold bull market of our lifetime… (From Golden Portfolio)

Up to $400 Million in Fraudulent Pandemic Loans in…

January 09, 2026

TODAY IN HISTORY Apple launches iTunes, revolutionizing how people consume music 2001 TOP STORIES Up to $400 Million in Fraudulent Pandemic Loans in Minnesota Alone: SBA Chief Kelly Loeffler The Small Business Administration (SBA) recently suspended nearly 7,000 Minnesota borrowers for suspected fraud in pandemic-era small business loans totaling nearly $400 million. SHARE*     WATCH NOWWhy Trump Canceled 2nd Wave of Venezuela Strikes SHARE*     READ MOREOur New Year Deal Is OnIn a world where partisan and biased reporting has become commonplace, you can always count on The Epoch Times for a refreshing dose of factual, honest journalism without spin. When you don’t feel like reading the news, pick up a daily tip from us. From what to do with potentially harmful roasting byproducts in your coffee to how screen time can affect different organs, our health coverage is deep and extensive. You will find your kind of healthy changes to make right away. Yet what makes you truly love The Epoch Times may be none of the above. It is our talks on art, culture, and history that move hearts. At nighttime or on an indolent Sunday afternoon, find yourself indulging in a fascinating read on stories you have been longing for: Pearl Harborthrough the eyes of a navy salvage diver, the sparkly stories behind the stolen Louvre jewels, the reasons why you should throw a party this holiday season… The list is endless. The inspiration is infinite. Subscribe to The Epoch Times with our  New Year Offer: 25¢ a week for 6 months. Start experiencing the kind of publication you won’t find anywhere else. Subscribe Now  >>> CDC Warns of Significant Measles Uptick Across US; Most Cases Recorded in 33 Years Facts Matter        WATCH NOWDoes Keto Diet or Intermittent Fasting Drop Weight Faster? Which One is Safer, and Easier to Stick to? Vital Signs        WATCH NOWHEALTH The Science Behind the New Dietary Guidelines SHARE*       READ MOREYoung Men Are Injecting Peptides to Transform Their Bodies, Despite Safety Risks SHARE*       READ MORESponsored Content 5 ‘Golden Rules’ to Create the Perfect European Cheese Board: Will You Join the Challenge? Sponsored       READ MOREINSPIRING 7 Proven Money Mindset Shifts to Save More and Stress Less SHARE*       READ MORELIFESTYLE Creamy Tomato Tortellini SHARE*       READ MOREEPOCH FUN Freecell SolitaireArrange cards by suit in ascending order to win.PLAYSpot the DifferenceFind the differences between 2 images.PLAYWord WipeCreate words to eliminate tiles.PLAY

Share this email  with a friend. Forward Received this email  from a friend? Subscribe Trouble viewing this  email? View in browser     Copyright © 2026 The Epoch Times, All rights reserved. The Epoch Times. 229 W. 28 St. Fl. 7 New York, NY 10001 | Contact Us * When sharing an article, giftaccess@TheEpochTimes.com is added to the list of recipients. If your friend is not already a subscriber, we will send them a special link for free access to the article.  Our Good Evening newsletter helps you catch up on the big stories of the day followed by lifestyle and uplifting content. Manage your email preferences here or unsubscribe from Good Evening here.

Night Prayer

Night Prayer for January 5, 2026.

Night Prayer

Jesus Christ, my God, I adore You and thank You for all the graces You have given me this day. I offer You my sleep and all the moments of this night. I place myself and all my loved ones, wherever they may be, in Your sacred side and under the mantle of Our Blessed Mother. Let Your holy angels stand watch and keep us in peace. Amen.

Quote of the Night

To holy people the very name of Jesus is a name to feed upon, a name to transport. His name can raise the dead and transfigure and beautify the living.— St. John Neumann

Today’s Meditation

Because they are without holdings, the meek actually hold everything. We see this patently in the life of St. Francis. the poet’s fancy of ” swinging the earth a trinket at my wrist” became spiritual reality in the little Poor Man of Assis. that all the earth was his is apparent in the way Francis dealt with the earth. He communed with it, eulogized it, singing expressions of its Creator, was literally familial with it. There was never a man more at home in creation than meek Francis of Assisi. To the pilgrim alone belongs the land, for the pilgrim is only happily passing through. He is not about to declare wars of colonization. He does not in fact need colonies. He has it all. Thus there is this reposefulness about the meek. Without aggressiveness (he suffers no grinding to possess), without arrogance (for he is a son and an heir of a Master whose infinite holdings are never in jeopardy and who asigns meekness as birthright to His progeny), he is at rest.—P. 30 Mother Mary Frances, PCC

AN EXCERPT FROMBlessed Are You: Reflections On The Beatitudes

RECOMMENDED PRODUCTS

• I Said A Prayer For You Today Laminated Holy Card ≻
• Monstrance Rosary Pouch ≻

Compline

Read Now

RECOMMENDED PRODUCTS

• St. John Paul II Peruvian Dark Roast Coffee ≻
• Madonna & Child Purse and Rosary Set ≻

Examination of Conscience

The daily examination of conscience is an ancient Catholic practice. It’s very simple, and it’s designed to help us identify our sins and weaknesses so that we can improve and grow stronger in the spiritual life. Basically, it consists in taking a few minutes at the end of the day to prayerfully review our actions in the light of God’s commandments. The Act of Contrition is often said afterwards. The daily examination also serves as an excellent ongoing preparation for regular Confession.

Reflect on the victories and losses

Actively reflecting on the high and low points of the day can help you live more intentionally and bring a renewed sense of resolve into the following day.

• Review your actions, words, and thoughts today. Did you actively guard yourself against temptation? Where did sin creep in?
• In what moments did you practice virtue and moral courage?
• Were you attuned to the Holy Spirit’s promptings today? Where did you feel His inspiration?
• Ask Him for the graces necessary to follow His Will more purposefully tomorrow.

Act of Contrition

O my God, I am heartily sorry for having offended Thee, and I detest all my sins because of Thy just punishments, but most of all because they offend Thee, my God, Who art all good and deserving of all my love. I firmly resolve with the help of Thy grace to sin no more and to avoid the near occasions of sin. Amen.

Practice gratitude

It is God’s love that has brought you into existence and to this exact moment. Practice looking for His hand in your day. 

• Where did you feel His loving gaze upon you today?
• What people or moments helped you see God in your life?
• Thank God for all these moments!
• Ask Him to help you recognize His blessings and providence tomorrow.

Renew your commitment to Christ

Remember our Faith is founded upon a Person—Christ! Renew your personal love and devotion to Him.

• Thank God for the gift of His Son Jesus and our call to be His disciples.
• Tell the Lord of your desire to know Christ more personally.
• If possible, set an intention for your day tomorrow. Ask Our Lord to guide you in this act.
• Pray a Hail Mary, Our Father, or another beloved prayer.

Rest With God

My people will abide in a peaceful habitation, in secure dwellings, and in quiet resting places. — Isaiah 32:18

RECOMMENDED PRODUCTS

• Bedtime Prayer Cube ≻
• Wooden Kiddie Rosary ≻

• PRAYER CALENDAR

   

© 2026 Night Prayer™ Privacy Policy Terms of Service Do Not Share My Information

https://creatives.attn.tv/creatives-dynamic/multiPage/index.html

Why Christians Shouldn’t Fear the Judgement Seat of Christ

Daily Verse    Reading Plans    PlusWhy Christians Shouldn’t Fear the Judgement Seat of Christ Lisa Loraine BakerWhat Are the Most Dangerous Verses in the Bible? Michael Jakes4 Unchanging Traits of God to Quiet Fear Jennifer SlatteryFree Devotional: God’s Promises for an Anxious Heart by Billy Graham Sponsor: Billy Graham Evangelistic Association8 Scriptures to Inspire You When You Feel Stuck Aaron D’Anthony Brown5 Real Blessings for Single Christians Blair Parke2 Powerful Miracles That Remind Us God Always Fights Our Battles Jennifer Slattery10 Powerful Psalms Every Christian Should Memorize Bethany VerrettHow Do We Grow in the Grace and Knowledge of Christ? Lisa Loraine BakerWhat Is the Chronological Order of the 66 Books of the Bible? Jessica BrodieHow Tall Was Goliath Really? Compiled & Edited by BibleStudyTools Staff

View this email in your browserAbout Salem Web Network | Subscription Preferences | Unsubscribe ©2026 Salem Web Network. All rights reserved. 111 Virginia Street, Suite 200, Richmond, VA 23219.This email is never sent unsolicited. You are receiving this email because your email address, peter.hovis@gmail.com, is signed up to receive newsletters, updates, and special offers from BibleStudyTools.

New Year Winter Sale!

Copyright © North Bay GMC, All rights reserved. Our mailing address is: 720 Northern Blvd, Great Neck, NY Want to change how you receive these emails? You can update your preferences or unsubscribe from this list

With a $7 Valuation, NNVC Could Disrupt the Biotech…

A message from Interactive Offers

NanoViricides (NNVC) Nears Critical Inflection Point with NV-387 Phase 2 Trials That Could Lead to Multi-Billion-Dollar Potential as Zacks Small Cap Research Issues $7 Valuation!NanoViricides (NYSE: NNVC) is turning heads in the biotech world as the company is advancing its lead drug candidate NV-387 into Phase 2 trials for MPox, targeting the most recent outbreaks and potential U.S. biodefense applications. Leveraging its nanomedicine platform, NV-387 has demonstrated broad antiviral activity in preclinical models against measles, influenza, RSV, and orthopoxviruses. With orphan drug designation applications in progress and dual-track trials planned, NNVC is strategically positioned to capture multiple markets while delivering a first-of-its-kind broad-spectrum antiviral therapy! According to Zacks Small Cap Research, the combination of NV-387’s safety record, proven efficacy in animal models, and regulatory strategy offers a compelling investment case. Zacks highlights the upside potential from government stockpile procurement, orphan drug incentives, and BARDA funding, which could provide non-dilutive capital and accelerate commercial adoption. With these catalysts on the horizon, NV-387 could become an essential therapy for viral threats worldwide and could make NNVC a breakout story in the biotech space next year. Learn why NNVC is on the verge of redefining the antiviral market

This is a paid advertisement provided to customers of Schaeffer’s Investment Research. Although we have sent you this email, Schaeffer’s does not necessarily endorse this product nor is it responsible for the content of this advertisement. Schaeffer’s makes no guarantee or warranty about what is advertised above.  To stop receiving these emails, unsubscribe.  Schaeffer’s Investment Research  5151 Pfeiffer Road, Suite 450  Cincinnati, Ohio 45242